Edwards Lifesciences Corporation Provides Earnings Guidance for the Third Quarter of 2022; Provides Earnings Guidance for the Year 2022
For the year, the company expects full year 2022 sales of $5.35 to $5.55 billion.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
85.25 USD | +0.22% | -1.37% | +11.80% |
05-01 | Edwards Lifesciences Insider Sold Shares Worth $1,212,687, According to a Recent SEC Filing | MT |
04-30 | Edwards Lifesciences Insider Sold Shares Worth $622,062, According to a Recent SEC Filing | MT |
1st Jan change | Capi. | |
---|---|---|
+11.80% | 51.37B | |
+7.84% | 218B | |
+7.35% | 184B | |
+13.04% | 135B | |
+26.03% | 107B | |
-1.33% | 62.38B | |
+4.81% | 50.9B | |
+0.30% | 40.87B | |
+2.78% | 36.28B | |
+26.14% | 31.88B |